TNF-alpha Inhibitors edited by Jeffrey M. Weinberg, Robin Buchholz.

Over the last decade, the advent of biologic agents has greatly revolutionized therapeutic medicine in the management of chronic inflammatory diseases, such as rheumatoid arthritis, Crohn’s disease, and psoriasis. Elucidation of the complex web of cytokine network and the roles of these cytokines in...

Full description

Saved in:
Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Weinberg, Jeffrey M. (Editor), Buchholz, Robin (Editor)
Format: eBook
Language:English
Published: Basel : Birkhäuser Basel : Imprint: Birkhäuser, 2006.
Edition:1st ed. 2006.
Series:Milestones in Drug Therapy,
Springer eBook Collection.
Subjects:
Online Access:Click to view e-book
Holy Cross Note:Loaded electronically.
Electronic access restricted to members of the Holy Cross Community.

MARC

LEADER 00000nam a22000005i 4500
001 b3266321
003 MWH
005 20191028142121.0
007 cr nn 008mamaa
008 100301s2006 sz | s |||| 0|eng d
020 |a 9783764374389 
024 7 |a 10.1007/3-7643-7438-1  |2 doi 
035 |a (DE-He213)978-3-7643-7438-9 
050 4 |a E-Book 
072 7 |a MJCM  |2 bicssc 
072 7 |a MED044000  |2 bisacsh 
072 7 |a MJCM  |2 thema 
245 1 0 |a TNF-alpha Inhibitors  |h [electronic resource] /  |c edited by Jeffrey M. Weinberg, Robin Buchholz. 
250 |a 1st ed. 2006. 
264 1 |a Basel :  |b Birkhäuser Basel :  |b Imprint: Birkhäuser,  |c 2006. 
300 |a X, 133 p. 10 illus.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Milestones in Drug Therapy,  |x 2296-6056 
490 1 |a Springer eBook Collection 
505 0 |a to TNF/pathophysiology of TNF -- History of development of TNF inhibitors -- Pharmacology of TNF inhibitors -- Etanercept in rheumatology -- Etanercept in dermatology and off-label use -- Infliximab in rheumatology -- Infliximab in dermatology, gastroenterology, and off-label use -- Adalimumab in rheumatology -- Adalimumab in dermatology -- A review of the safety of the tumor necrosis inhibitors infliximab, etanercept, and adalimumab. 
520 |a Over the last decade, the advent of biologic agents has greatly revolutionized therapeutic medicine in the management of chronic inflammatory diseases, such as rheumatoid arthritis, Crohn’s disease, and psoriasis. Elucidation of the complex web of cytokine network and the roles of these cytokines in the pathogenesis of inflammatory disorders provided one of the key catalysts for the advancement of targeted biologic therapy in autoimmune and inflammatory diseases. TNF-alpha is known to play a crucial role in the pathogenesis of many chronic inflammatory diseases. Elevated levels of TNF-alpha have been demonstrated in Crohn’s disease, psoriasis, psoriatic arthritis, and rheumatoid arthritis, suggesting a role for TNF-alpha in their pathogenesis. Although TNF-alpha plays a critical role in the activation of innate and acquired immune responses, the persistence of the immune response and inappropriate production of TNF-alpha can produce pathological changes resulting from chronic inflammation and tissue damage. This volume provides a comprehensive overview of the development, pharmacology, efficacy, and safety of the currently available TNF-alpha inhibitors – etanercept, infliximab, and adalimumab. The most recent preclinical and clinical data is presented on this topic, which should be of interest to the preclinical researcher, the clinician, and the patient who wants to learn more about these therapies. 
590 |a Loaded electronically. 
590 |a Electronic access restricted to members of the Holy Cross Community. 
650 0 |a Immunology. 
650 0 |a Rheumatology. 
650 0 |a Dermatology. 
650 0 |a Pharmacology. 
650 0 |a Gastroenterology . 
690 |a Electronic resources (E-books) 
700 1 |a Weinberg, Jeffrey M.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
700 1 |a Buchholz, Robin.  |e editor.  |4 edt  |4 http://id.loc.gov/vocabulary/relators/edt 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
830 0 |a Milestones in Drug Therapy,  |x 2296-6056 
830 0 |a Springer eBook Collection. 
856 4 0 |u https://holycross.idm.oclc.org/login?auth=cas&url=https://doi.org/10.1007/3-7643-7438-1  |3 Click to view e-book  |t 0 
907 |a .b32663213  |b 04-18-22  |c 02-26-20 
998 |a he  |b 02-26-20  |c m  |d @   |e -  |f eng  |g sz   |h 0  |i 1 
912 |a ZDB-2-SBL 
950 |a Biomedical and Life Sciences (Springer-11642) 
902 |a springer purchased ebooks 
903 |a SEB-COLL 
945 |f  - -   |g 1  |h 0  |j  - -   |k  - -   |l he   |o -  |p $0.00  |q -  |r -  |s b   |t 38  |u 0  |v 0  |w 0  |x 0  |y .i21794832  |z 02-26-20 
999 f f |i 544c58e7-c061-5b8f-8dc4-8952979a171d  |s 19a6c32e-18d6-5933-a22f-1990edb728eb  |t 0 
952 f f |p Online  |a College of the Holy Cross  |b Main Campus  |c E-Resources  |d Online  |t 0  |e E-Book  |h Library of Congress classification  |i Elec File